1. World Health Organisation. 2020 antibacterial agents in clinical and preclinical development: an overview and analysis.
2. Jonas OB, Irwin A, Berthe F, Jean C, Le Gall FG, Marquez PV. Drug-resistant infections: a threat to our economic future (vol. 2): final report (English). HNP/Agriculture Global Antimicrobial Resistance Initiative Washington, DC: World Bank Group 2016. http://documents.worldbank.org/curated/en/323311493396993758/final-report.
3. The Organisation for Economic Co-operation and Development (OECD). Stemming the superbug tide: just a few dollars more. 2018.
4. Office for National Statistics. Gross Domestic Product: United Kingdom March 2021. https://www.ons.gov.uk/economy/grossdomesticproductgdp/timeseries/abmi/ukea. Cited 1 June 2021.
5. Smith RD, Yago M, Millar M, Coast J. Assessing the macroeconomic impact of a healthcare problem: the application of computable general equilibrium analysis to antimicrobial resistance. J Health Econ. 2005;24(6):1055–75.